PT90464A - Processo de preparacao de derivados da guanina imuno-estimulantes e de composicoes farmaceuticas que os contem - Google Patents

Processo de preparacao de derivados da guanina imuno-estimulantes e de composicoes farmaceuticas que os contem

Info

Publication number
PT90464A
PT90464A PT90464A PT9046489A PT90464A PT 90464 A PT90464 A PT 90464A PT 90464 A PT90464 A PT 90464A PT 9046489 A PT9046489 A PT 9046489A PT 90464 A PT90464 A PT 90464A
Authority
PT
Portugal
Prior art keywords
derivatives
guanina
stimulants
immuno
pharmaceutical compositions
Prior art date
Application number
PT90464A
Other languages
English (en)
Other versions
PT90464B (pt
Inventor
Michael Goodman
Robert Chen
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of PT90464A publication Critical patent/PT90464A/pt
Publication of PT90464B publication Critical patent/PT90464B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT90464A 1988-05-05 1989-05-04 Processo de preparacao de derivados da guanina imuno-estimulantes e de composicoes farmaceuticas que os contem PT90464B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/190,694 US5093318A (en) 1983-11-01 1988-05-05 Immunostimulating guanosine derivatives and their pharmaceutical compositions

Publications (2)

Publication Number Publication Date
PT90464A true PT90464A (pt) 1989-11-30
PT90464B PT90464B (pt) 1994-12-30

Family

ID=22702383

Family Applications (1)

Application Number Title Priority Date Filing Date
PT90464A PT90464B (pt) 1988-05-05 1989-05-04 Processo de preparacao de derivados da guanina imuno-estimulantes e de composicoes farmaceuticas que os contem

Country Status (12)

Country Link
US (1) US5093318A (pt)
EP (1) EP0341066B1 (pt)
JP (1) JP2790846B2 (pt)
AT (1) ATE113957T1 (pt)
AU (1) AU619539B2 (pt)
CA (1) CA1320196C (pt)
DE (1) DE68919266T2 (pt)
DK (1) DK170780B1 (pt)
ES (1) ES2063125T3 (pt)
GR (1) GR3015018T3 (pt)
IE (1) IE66321B1 (pt)
PT (1) PT90464B (pt)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011828A (en) * 1985-11-15 1991-04-30 Michael Goodman Immunostimulating guanine derivatives, compositions and methods
US7307166B1 (en) 1987-10-28 2007-12-11 Wellstat Therapeutics Corporation Oxpurine nucleosides and their congeners, and acyl, derivatives thereof, for improvement of hematopoiesis
IE882585L (en) * 1988-08-25 1990-02-25 Prendergast Patrick T Viral treatment system
AU5165793A (en) * 1992-10-01 1994-04-26 Mcneilab, Inc. Derivatives of 7,8-disubstituted guanosines
US6727230B1 (en) * 1994-03-25 2004-04-27 Coley Pharmaceutical Group, Inc. Immune stimulation by phosphorothioate oligonucleotide analogs
US5441942A (en) * 1994-05-27 1995-08-15 The Scripps Research Institute 2'3'-dideoxy-2',3'-didehydro-7,8-disubstituted guanosines and their immunostimulative effect
US5382580A (en) * 1994-05-27 1995-01-17 The Scripps Research Institute N9 morpholino derivatives of 7,8-disubstituted guanines
US5786359A (en) * 1994-05-27 1998-07-28 The Scripps Research Institute N9 alkyl or aralkyl derivatives of 7, 8-disubstituted guanines
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
US5773424A (en) * 1994-12-16 1998-06-30 Research Corporation Technologies, Inc. Treatment of toxoplasmosis
US20030100520A1 (en) * 1997-01-21 2003-05-29 Philip Needleman Immunological process and constructs for increasing the hdl cholesterol concentration by dna vaccination
US6303617B1 (en) 1998-05-04 2001-10-16 Neotherapeutics, Inc. Serotonin-like 9-substituted hypoxanthine and methods of use
AU4244400A (en) * 1999-04-15 2000-11-02 Board Of Regents, The University Of Texas System Ppgpp and pppgpp as immunomodulatory agents
US6949520B1 (en) * 1999-09-27 2005-09-27 Coley Pharmaceutical Group, Inc. Methods related to immunostimulatory nucleic acid-induced interferon
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US20010044416A1 (en) * 2000-01-20 2001-11-22 Mccluskie Michael J. Immunostimulatory nucleic acids for inducing a Th2 immune response
US7585847B2 (en) 2000-02-03 2009-09-08 Coley Pharmaceutical Group, Inc. Immunostimulatory nucleic acids for the treatment of asthma and allergy
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) * 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
US6630490B2 (en) 2000-07-07 2003-10-07 Neotherapeutics, Inc. Methods for treatment of disease-induced peripheral neuropathy and related conditions
US20030138769A1 (en) * 2000-08-16 2003-07-24 Birkett Ashley J. Immunogenic HBc chimer particles having enhanced stability
WO2002069369A2 (en) * 2000-12-08 2002-09-06 Coley Pharmaceutical Gmbh Cpg-like nucleic acids and methods of use thereof
US6759427B2 (en) * 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
US7361352B2 (en) 2001-08-15 2008-04-22 Acambis, Inc. Influenza immunogen and vaccine
US20030185858A1 (en) * 2001-08-15 2003-10-02 Birkett Ashley J. Immunogenic HBc chimer particles stabilized with an N-terminal cysteine
US20030175863A1 (en) * 2001-08-15 2003-09-18 Birkett Ashley J. Influenza immunogen and vaccine
US7351413B2 (en) * 2002-02-21 2008-04-01 Lorantis, Limited Stabilized HBc chimer particles as immunogens for chronic hepatitis
EP1608403A2 (en) * 2003-04-02 2005-12-28 Coley Pharmaceutical Group, Ltd. Immunostimulatory nucleic acid oil-in-water formulations for topical application
ES2317583T3 (es) * 2005-09-22 2009-04-16 F. Hoffmann-La Roche Ag O-acilacion selectiva de nucleosidos.
WO2009016639A2 (en) 2007-08-02 2009-02-05 Biondvax Pharmaceuticals Ltd. Multimeric multiepitope influenza vaccines
AU2008331800A1 (en) 2007-12-03 2009-06-11 President And Fellows Of Harvard College Chlamydia antigens
JP2012510289A (ja) 2008-12-03 2012-05-10 プロティア ワクチン テクノロジーズ リミテッド グルタミルｔＲＮＡ合成酵素（ＧｔＳ）フラグメント
WO2011067758A2 (en) 2009-12-02 2011-06-09 Protea Vaccine Technologies Ltd. Immunogenic fragments and multimers from streptococcus pneumoniae proteins
WO2012114323A1 (en) 2011-02-22 2012-08-30 Biondvax Pharmaceuticals Ltd. Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
ES2702278T3 (es) 2012-04-01 2019-02-28 Technion Res & Dev Foundation Péptidos de inductor de metaloproteinasa de matriz extracelular (emmprin) y anticuerpos de unión
US10426828B2 (en) 2014-04-03 2019-10-01 Biondvax Pharmaceuticals Ltd. Compositions of multimeric-multiepitope influenza polypeptides and their production
CR20200649A (es) 2018-05-25 2021-05-11 Primmune Therapeutics Inc Agosnistas de tlr7

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4539205A (en) * 1982-11-09 1985-09-03 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US4948730A (en) * 1982-11-09 1990-08-14 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US4643992A (en) * 1982-11-09 1987-02-17 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US5011828A (en) * 1985-11-15 1991-04-30 Michael Goodman Immunostimulating guanine derivatives, compositions and methods

Also Published As

Publication number Publication date
CA1320196C (en) 1993-07-13
DE68919266T2 (de) 1995-06-01
US5093318A (en) 1992-03-03
IE66321B1 (en) 1995-12-27
PT90464B (pt) 1994-12-30
IE891463L (en) 1989-11-05
AU619539B2 (en) 1992-01-30
EP0341066A2 (en) 1989-11-08
EP0341066A3 (en) 1990-05-30
DE68919266D1 (de) 1994-12-15
JPH0256496A (ja) 1990-02-26
EP0341066B1 (en) 1994-11-09
DK217289A (da) 1989-11-06
GR3015018T3 (en) 1995-05-31
DK217289D0 (da) 1989-05-03
DK170780B1 (da) 1996-01-15
JP2790846B2 (ja) 1998-08-27
ES2063125T3 (es) 1995-01-01
ATE113957T1 (de) 1994-11-15
AU3399989A (en) 1989-11-09

Similar Documents

Publication Publication Date Title
PT90465A (pt) Processo de preparacao de derivados da guanina imuno-estimulantes e de composicoes farmaceuticas que os contem
DK217289A (da) Substitueret guanin-nukleosid-derivat, praeparater fremstillet deraf, samt dets anvendelse som laegemiddel
FI900412A0 (fi) Antiviral eller antibakteriell foerening och foerfarande foer anvaendning daerav.
PT90893A (pt) Processo de preparacao de derivados da pirimidina, de seus intermediarios e de composicoes farmaceuticas que os contem
NO883555L (no) Innretning for applisering av implantater.
PT93241A (pt) Processo de preparacao de derivados de piperidina e de composicoes farmaceuticas que os contem
LV5624A3 (lv) Panemiens 5'-dezoksi-5-fluorcitidina atvasinajumu iegusanai
ATE82684T1 (de) Mittel zur behandlung und zum schutz der haut.
YU47543B (sh) Postupak za dobijanje farmaceutskog preparata za stimulaciju granulocita
IT1219857B (it) Composizioni di cura della pelle e metodo per applicarle
PT76502A (en) Process for the preparation of n-glycosylated carboxamide derivatives with s stimulating effect of the body's inherent defences and their application for the preparation of pharmaceutical compositions having a stimulating effect of body's inherent defences
PT92466A (pt) Processo de preparacao de derivados do quitosano e de composicoes e granulados que os contem
DK209187A (da) Anvendelse af adenosin-derivater til behandling af demens
DK447288A (da) Kombination af pyrimidinderivater og retinoider som separate komponenter til fremkaldelse og stimulation af haarvaekst samt reduktion af tab deraf
DE59001005D1 (de) Hilfsmittelfreie riboflavingranulate.
IT1234230B (it) Solfonammidi di benzilidene canfora derivanti da amminoacidi e loro impiego in cosmesi particolarmente come filtri solari
PH27533A (en) Adenosine derivative pharmaceutical composition and method of use thereof
PT98766A (pt) Processo de preparacao de derivados de quinobenzoxazina quinobenzotiazina e pirido-acridina e de composicoes farmaceuticas que os contem
IT1211544B (it) Cosmetico dei capelli utilizzante composizione per indurre e stimola tale composizione re la crescita dei capelli e ridurre la caduta a base di derivati di alchilen diammino chinazolina associazione contenente tale composizione utilizzazione della composizione per la preparazione di un medicinale e procedimento di trattamento
IT1241676B (it) Emulsione stabile sostanzialmente anidra da impiegare come veicolo di una sostanza o composizione nutritiva, cosmetica o terapeutica
BR8901161A (pt) Complexo;composicao farmaceutica;e processo para estimular celulas para que estas produzam linfocinas
FR2564731B1 (fr) Nouvelles fractions exo-antigeniques toxoplasmiques, leur procede de preparation et leur application a la recherche de l'immunite toxoplasmique chez l'homme par tests cutanes
BR8802315A (pt) Composicao reguladora do crescimento da planta e processo de regular o crescimento de uma planta
MX9100786A (es) Metodos y composiciones que contienen compuestos de vitamina d para mejorar las condiciones de la piel
PT89371A (pt) Processo de preparacao de 1-aralquil-1,2-di-hidropirimidina-2-tionas e de composicoes farmaceuticas que as contem

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19940608

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20081209

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20090608